AG

Adam Goulburn

Founder of Dimension

New York, New York

Overview 

Adam Goulburn is the Founder of Dimension, a venture capital firm in New York, with a focus on investing in lifesciences, regenerative medicine, and biotechnology startups. He has a successful track record of founding and leading companies like VNV Bio (now Aera Therapeutics) and Kallyope, along with making strategic investments in companies like Kaleidoscope, Rivet, and Science 37. With a PhD from Monash University and a background in venture capital at Lux Capital, Adam Goulburn has established himself as a prominent figure in the startup ecosystem, particularly in the health and biotech sectors, through his leadership roles in various successful ventures and investments in innovative companies.

Work Experience 

  • Co-Founder

    2022 - Current

Dimension Capital is a venture capital firm that prefers to invest in various industries.

  • Venture Partner

    2022 - 2022

  • Partner

    2015 - 2022

  • Principal

    2014 - 2015

  • Senior Associate

    2012 - 2014

  • Associate

    2011 - 2012

Lux Capital is an investment firm that invests in counter-conventional, seed-stage science and technology ventures.

  • Founding CEO

    2018 - 2021

  • Founding CEO

    2014 - 2015

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Raised $487,200,000.00 from Bill & Melinda Gates Foundation.

  • Post-Doctoral Associate

    2010 - 2011

    Fellow of Neuroscience

Weill Cornell Medicine is an academic medical institution that offers health care services.

Raised $53,500,000.00 from National Cancer Institute, National Institutes of Health, UnitedHealthcare and National Institutes of Health.

Articles About Adam

Relevant Websites